RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK)

Germany flag Germany · Delayed Price · Currency is EUR
12.10
+0.20 (1.68%)
Jul 11, 2025, 5:36 PM CET
-0.82%
Market Cap 809.96M
Revenue (ttm) 1.89B
Net Income (ttm) 39.69M
Shares Out 66.94M
EPS (ttm) 0.60
PE Ratio 20.21
Forward PE 17.04
Dividend 0.10 (0.84%)
Ex-Dividend Date Jun 4, 2025
Volume 100
Average Volume 3,682
Open 11.70
Previous Close 11.90
Day's Range 11.70 - 12.10
52-Week Range 10.10 - 16.40
Beta -0.03
RSI 46.07
Earnings Date Aug 7, 2025

About ETR:RHK

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. It also operates acute hospitals, medical care centers, and rehabilitation hospitals. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany. [Read more]

Sector Healthcare
Founded 1973
Employees 14,067
Stock Exchange Deutsche Börse Xetra
Ticker Symbol RHK
Full Company Profile

Financial Performance

In 2024, ETR:RHK's revenue was 1.87 billion, an increase of 7.67% compared to the previous year's 1.73 billion. Earnings were 43.35 million, an increase of 11.98%.

Financial Statements

News

Rhoen-Klinikum Steady in Q1 2025, Confirms Positive Outlook

In Q1 2025, RHÖN-KLINIKUM AG treated over 240,000 patients, achieving an 8.3% revenue increase, despite economic challenges. Strategic partnerships and a focus on quality care position them for future...

2 months ago - Wallstreet:Online

Rhoen-Klinikum's Prof. Kaltenbach Exits After Stellar Year

RHÖN-KLINIKUM AG celebrates a thriving year, with revenues soaring and patient numbers climbing, as it sets ambitious targets for a sustainable future. Jetzt den vollständigen Artikel lesen

3 months ago - Wallstreet:Online

EQS-News: RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Management as planned

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Annual Report/Annual Results RHÖN-KLINIKUM AG once again reports a successful financial year – CEO Prof. Kaltenbach leaves the Board of Manage...

3 months ago - Wallstreet:Online

Rhoen-Klinikum Shines: Strong 9-Month Performance, Outlook Confirmed

RHÖN-KLINIKUM AG has shown robust growth in 2024, with significant increases in revenue, profit, and patient numbers, underscoring its position as a leading healthcare provider in Germany. Jetzt den v...

8 months ago - Wallstreet:Online

RHÖN-KLINIKUM AG: Strong H1 2024 Performance, Confident Outlook Ahead

RHÖN-KLINIKUM AG saw a robust first half of 2024, with revenues climbing 6.5% to 775.5 million euros and profits soaring 68.9% to 20.6 million euros, despite a tough market. Patient numbers and EBITDA...

1 year ago - Wallstreet:Online

EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Half Year Results/Miscellaneous First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed 08.08.2024 / 09:0...

1 year ago - Wallstreet:Online